Cargando…

Elevation of Fasting GLP-1 Levels in Child and Adolescent Obesity: Friend or Foe?

Glucagon-like peptide-1 (GLP-1) receptor agonists have been gaining much attention as a therapeutic approach to type 2 diabetes and obesity. Stinson et al recently reported that fasting GLP-1 is higher in children and adolescents with overweight/obesity and that it associates with cardiometabolic ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Sodai, Yabe, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372656/ https://www.ncbi.nlm.nih.gov/pubmed/33950185 http://dx.doi.org/10.1210/clinem/dgab301

Ejemplares similares

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
por: Liu, Yangyang, et al.
Publicado: (2020)

Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
por: Cena, Hellas, et al.
Publicado: (2020)

Data Resource Profile: National Child Oral Health Improvement Programmes for Chile
por: Celis, Andrés, et al.
Publicado: (2022)

Dichotomy in the Impact of Elevated Maternal Glucose Levels on Neonatal Epigenome
por: Lim, Ives Yubin, et al.
Publicado: (2021)

Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)

Relationships of Glucose, GLP-1, and Insulin Secretion With Gastric Emptying After a 75-g Glucose Load in Type 2 Diabetes
por: Jalleh, Ryan J, et al.
Publicado: (2022)

Dipeptidyl peptidase‐4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
por: Yabe, Daisuke, et al.
Publicado: (2014)

Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis
por: Messina, Valeria, et al.
Publicado: (2020)

Weight Loss Improves β-Cell Function in People With Severe Obesity and Impaired Fasting Glucose: A Window of Opportunity
por: Rothberg, Amy E, et al.
Publicado: (2019)

Distribution of Tri-Ponderal Mass Index and its Relation to Body Mass Index in Children and Adolescents Aged 10 to 20 Years
por: Park, Hong Kyu, et al.
Publicado: (2020)

Effects of Different Doses of Exercise on Inflammation Markers Among Adolescents With Overweight/Obesity: HEPAFIT Study
por: Ramírez-Vélez, Robinson, et al.
Publicado: (2022)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Child and Family Factors Associated With Child Maltreatment in Vietnam
por: Tran, Nhu K., et al.
Publicado: (2018)

Ketogenic Diet for Obesity: Friend or Foe?
por: Paoli, Antonio
Publicado: (2014)

Adiponectin: friend or foe in obesity and inflammation
por: Luo, Liping, et al.
Publicado: (2022)

Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
por: Zeng, Chengbo, et al.
Publicado: (2022)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
por: Pang, Juan, et al.
Publicado: (2021)

Vitamin D(3) Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly
por: Bacha, Dania S, et al.
Publicado: (2021)

Friend and Foe
Publicado: (1890)

Metabolically healthy obesity: a friend or foe?
por: Jung, Chang Hee, et al.
Publicado: (2017)

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
por: Smith, Lorey K., et al.
Publicado: (2020)

The Nrf2 in Obesity: A Friend or Foe?
por: Xia, Yudong, et al.
Publicado: (2022)

Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome
por: Abbara, Ali, et al.
Publicado: (2021)

IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
por: Joustra, Sjoerd D, et al.
Publicado: (2019)

The role and its mechanism of intermittent fasting in tumors: friend or foe?
por: Zhao, Xu, et al.
Publicado: (2021)

Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level–Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study
por: Segeral, Olivier, et al.
Publicado: (2020)

GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
por: Taing, Meng-Wong, et al.
Publicado: (2014)

Talking About Feelings: Mother–Child Emotion Dialogues Among Sexually Abused Children
por: van Delft, Ivanka, et al.
Publicado: (2018)

Obesity Due to Steroid Receptor Coactivator-1 Deficiency Is Associated With Endocrine and Metabolic Abnormalities
por: Cacciottolo, Tessa M, et al.
Publicado: (2022)

Obesity, Thyroid Nodularity, and Thyroid Cancer: Epiphenomenon or Cause?
por: Bradley, David
Publicado: (2020)

Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort
por: Tapia, German, et al.
Publicado: (2021)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dfa51sq0eoqtc48r5u2r2f5vqq